GENMAB A/S's ticker is GMAB and the CUSIP is 372303206. A total of 209 filers reported holding GENMAB A/S in Q1 2023. The put-call ratio across all filers is 0.73 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $836 | -7.2% | 23,704 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $901 | -2.6% | 23,704 | -3.2% | 0.00% | 0.0% |
| Q1 2023 | $925 | +1.1% | 24,487 | +13.5% | 0.00% | 0.0% |
| Q4 2022 | $915 | -99.9% | 21,581 | -26.1% | 0.00% | -25.0% |
| Q3 2022 | $938,000 | -13.6% | 29,208 | -12.7% | 0.00% | 0.0% |
| Q2 2022 | $1,086,000 | -9.9% | 33,440 | +0.4% | 0.00% | 0.0% |
| Q1 2022 | $1,205,000 | -34.8% | 33,304 | -28.7% | 0.00% | -33.3% |
| Q4 2021 | $1,847,000 | +7.4% | 46,682 | +18.6% | 0.01% | 0.0% |
| Q3 2021 | $1,719,000 | -61.7% | 39,345 | -64.2% | 0.01% | -62.5% |
| Q2 2021 | $4,491,000 | +24.2% | 109,983 | -0.1% | 0.02% | +6.7% |
| Q1 2021 | $3,616,000 | -2.3% | 110,145 | +21.0% | 0.02% | -11.8% |
| Q4 2020 | $3,703,000 | – | 91,062 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 52,148 | $1,839,260 | 1.67% |
| Ativo Capital Management LLC | 28,442 | $1,003,132 | 1.13% |
| HARDING LOEVNER LP | 3,204,230 | $113,013,183 | 0.75% |
| Hardman Johnston Global Advisors LLC | 592,318 | $20,891,056 | 0.70% |
| Yorktown Management & Research Co Inc | 16,600 | $585,482 | 0.66% |
| TORRAY INVESTMENT PARTNERS LLC | 104,516 | $3,686,279 | 0.65% |
| First Light Asset Management, LLC | 157,147 | $5,542,575 | 0.53% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 44,300 | $1,561,575 | 0.53% |
| Capricorn Fund Managers Ltd | 37,007 | $1,305,237 | 0.45% |
| Legacy Wealth Asset Management, LLC | 29,496 | $1,040,324 | 0.38% |